PSYCHOMOTPAL: Evaluation of the Impact of Psychomotricity on the Patients Body Experience in Palliative Care

Sponsor
University Hospital, Strasbourg, France (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03959813
Collaborator
(none)
0
22

Study Details

Study Description

Brief Summary

Palliative care is part of a comprehensive approach to the person, in the advanced phase of a serious illness. The purpose of this care is to relieve painful symptoms, to promote comfort and quality of life. In the context of a serious illness, the sick person is confronted with body modifications that have an impact on his body experience, that is, on his feelings and on the image that he has of his body.

Psychomotricity is a paramedical discipline that focuses on body-psyche links. The psychomotor therapist is authorized to take care of psychomotor disorders, as defined in the decree of competences. These psychomotor disorders appear in connection with the evolution of the serious illness and the presence of symptoms in these patients (ex: disorders of the tonic regulation, psychomotor disharmony, disorders of the representation of the body, etc.). In palliative care, the psychomotor therapist seeks to regulate these psychomotor disorders and thus to promote a more satisfying physical experience in the patient, through the use of different bodily approaches.

Several studies have shown the beneficial effects of touching and moving the body in cancer patients, but no work evaluating the effects of the psychomotor approach (involving various body mediations) on the body experience of patients with cancer in palliative situation

Condition or Disease Intervention/Treatment Phase
  • Other: Psychomotricity by touching and passive mobilizations

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Evaluation of the Impact of Psychomotricity on the Patients Body Experience in Palliative Care
Actual Study Start Date :
Sep 1, 2019
Actual Primary Completion Date :
Jul 1, 2021
Actual Study Completion Date :
Jul 1, 2021

Outcome Measures

Primary Outcome Measures

  1. Realization of a questionnaire, based on the patient's global and physical feeling [30 minutes before psychomotor care]

    questionnaire used to assess the impact of psychomotor care on the body experience of patients with advanced palliative care cancer, in both a physical and psychological dimension

  2. Realization of a questionnaire, based on the patient's global and physical feeling [30 minutes after psychomotor care]

    questionnaire used to assess the impact of psychomotor care on the body experience of patients with advanced palliative care cancer, in both a physical and psychological dimension

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age greater than or equal to 18 years

  • Man or woman

  • Subject who has agreed to participate in the research and to use the data collected for research purposes

  • Patient with solid cancer or hematological malignancy in palliative stage, that is to say a cancerous disease for which no curative treatment is no longer envisaged, with committed vital prognosis

  • Hospitalize patient in palliative care unit

  • Patient with indication of care in psychomotricity defined by the decree of competence Decree n ° 88-659 of May 6, 1988

  • Patient with a minimum score of 4 on an item or a minimum score of 4 on several cumulative items (with a minimum of 2 on at least one of the items), on the ESAS scale, among the following themes: pain, anxiety, depression, uneasy feeling

Exclusion Criteria:
  • Patient whose clinical condition (left to the decision of the investigator) does not allow to perform a psychomotor care and / or participate in a recorded interview (extreme fatigue, confusion, painful uncontrolled symptoms)

  • Communication difficulties, patient not speaking or not understanding French

  • Impossibility of giving the patient informed information (subject in emergency situation, difficulties in understanding the subject, etc.)

  • Patient under guardianship, curatorship

  • Patient not affiliated to social welfare regime

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Strasbourg, France

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT03959813
Other Study ID Numbers:
  • 7254
First Posted:
May 22, 2019
Last Update Posted:
Sep 20, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Sep 20, 2021